NCT05215938

Brief Summary

The investigators aim to implement an innovative imaging tool for detection of sodium level changes in-vivo with a clinical magnetic resonance (MR) scanner system. Conventionally, MR imaging (MRI) is performed with the use of proton imaging. Nevertheless, detection of other nuclei such as sodium (23Na) are possible with dedicated radio frequency sequences and radio frequency antennas tuned to the lower radio frequency of sodium. Non-invasive detection of sodium level changes has great potential as a precursor of organ deficiency and possible organ failure. This project seeks to determine a robust method for detection and characterization of sodium levels with MRI. The sodium levels of the kidneys are known to change throughout the day. Therefore, an evaluation of the kidney circadian sodium level variation is performed. In the proposed project, the investigators will scan two groups divided into two separate studies: Healthy controls for optimization of imaging (n = 5, scanned twice) Healthy controls for comparison of circadian variation (n = 10, scanned triple on one day) Sodium MRI could greatly improve the understanding and diagnostic capabilities of several medical conditions. If successful, the proposed project will serve as the groundwork for future clinical studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 7, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 18, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 31, 2022

Completed
Last Updated

March 18, 2022

Status Verified

January 1, 2022

Enrollment Period

5 months

First QC Date

January 18, 2022

Last Update Submit

March 17, 2022

Conditions

Keywords

MRISodium imagingB1 field correctionKidney circadian sodium level variationMulti-organ

Outcome Measures

Primary Outcomes (1)

  • Evaluation of intra organ sodium levels by magnetic resonance imaging

    The overall aim of this study is to implement and validate an imaging protocol for detection of sodium level changes in-vivo and determine circadian sodium level variations. This will be carried out in two separate studies.

    6 months

Secondary Outcomes (2)

  • Study I: Multi-organ sodium imaging with B1 field correction

    6 months

  • Study II: Circadian sodium level variation in the kidney measured with MRI

    6 months

Study Arms (2)

Study I: Multi-organ sodium imaging with B1 field correction

The scan will be performed in four area of interests (AOFs) to acquire sodium level signal form the thigh, heart, kidneys, and brain. Between each AOF the sodium receive coil will be moved to cover the specific organ. Determination of the sodium imaging method robustness is performed with a series of MRI sequences. The scans at the four AOFs are repeated to evaluate repeatability. The scan time with repositioning of coils is approximately 15 min per station (total scan time 2 hours). If needed the participants are able to have a break between scan stations.

Diagnostic Test: MRI examination

Study II: Circadian sodium level variation in the kidney measured with MRI

Participation requires one full day at the MR Centre. MRI scans will be performed three times at the same day within the following time periods: 6.30-8.00 am. (before breakfast), 12.30-14-00 pm. (after lunch) and 21.00-22.00 pm. (after dinner). The scan time is expected to be 30-40 min at each scan (three scans are performed on one examination day), which requires a total scan time \~1½ hours. Participants are not allowed to perform excessive physical exercise the day before and during the study day. Lighter physical exercise as walking, biking etc. is accepted. Alcohol consuming is not allowed the day before and during the study day. The participants can drink and eat as usual, but all fluid intake and urinations shall be documented in a liquid urination schedule. Blood pressure will be measured at each scan session and urine samples are collected just after each scan session to assess the osmolarity.

Diagnostic Test: MRI examination

Interventions

MRI examinationDIAGNOSTIC_TEST

The magnetic resonance imaging session will be performed in a clinical 3T MRI scanner (GE healthcare). A commercial human intent non-diagnostic RF coil (PulseTeq) will be used for 23Na MRI. The scanner, coils and sequences are regularly used in research projects and validated for the same safety requirements as routinely used in the clinic. Nevertheless, the complete MRI session will be performed in research mode to use the advanced options (limits the usage to non-diagnostic purposes). Participants will be placed in a supine position with coils covering the area of interest (AOF). MRI examination will be performed by trained personnel.

Study I: Multi-organ sodium imaging with B1 field correctionStudy II: Circadian sodium level variation in the kidney measured with MRI

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy men and women in the ages of 20 to 60.

You may qualify if:

  • Participants are eligible if they can provide informed consent and meet the following criteria:
  • Healthy men and women aged 20-60 years.
  • Five participants of each gender are required in study II, whereto, gender is not of importance in study I.
  • Healthy is defined as no use of medicine besides from contraceptives and vitamins.

You may not qualify if:

  • The participants are not eligible if they fulfill any of the following criteria:
  • Persons with circumference including arms \> 160 cm. (MR scanner bore size)
  • Pregnant women are not allowed to volunteer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MR Research Centre

Aarhus N, 8200, Denmark

Location

Related Publications (2)

  • Vaeggemose M, Schulte RF, Hansen ESS, Miller JJ, Rasmussen CW, Pilgrim-Morris JH, Stewart NJ, Collier GJ, Wild JM, Laustsen C. A Framework for Predicting X-Nuclei Transmitter Gain Using 1H Signal. Tomography. 2023 Aug 24;9(5):1603-1616. doi: 10.3390/tomography9050128.

  • Rasmussen CW, Bogh N, Ringgaard S, Birn H, Vaeggemose M, Schulte RF, Laustsen C. Daytime Variation in Kidney Perfusion, Oxygenation, and Sodium Concentration Assessed by Multiparametric MRI in Healthy Volunteers. J Magn Reson Imaging. 2024 May;59(5):1603-1611. doi: 10.1002/jmri.28983. Epub 2023 Sep 1.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Urine samples to measure: Urinary albumin/creatinine excretion ratio, Na+, K+ and osmolarity. The laboratory analyses will be performed within seven days of collection and all urine samples will be eliminated afterwards.

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 18, 2022

First Posted

January 31, 2022

Study Start

July 7, 2021

Primary Completion

December 10, 2021

Study Completion

December 10, 2021

Last Updated

March 18, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

The study is performed on healthy subjects to evaluate sodium MR imaging feasibility. Even though results are of value to the field further studies would require inclusion of a patient group or an intervention.

Locations